Dyshidrosiform Palmoplantar Pemphigoid in a Young Man: Response to DapsoneLUPI, Francesca; MASINI, Cinzia; RUFFELLI, Marina et al.Acta dermato-venereologica. 2010, Vol 90, Num 1, pp 80-81, issn 0001-5555, 2 p.Article

Increase in the incidence of dapsone hypersensitivity syndrome : an appraisalNARASIMHA RAO, P; LAKSHMI, T. S. S.Leprosy review. 2001, Vol 72, Num 1, pp 57-62, issn 0305-7518Article

Une fièvre antillaise = A french antilles feverPERMAL-GRIFFITHS, S; DHOTE, R; DELEGUE, P et al.La Revue de médecine interne (Paris). 2001, Vol 22, pp 250s-252s, issn 0248-8663, SUP2Conference Paper

Unexplained acute severe methaemoglobinaemia in a young adultFALKENHAHN, M; KANNAN, S; O'KANE, M et al.British Journal of Anaesthesia. 2001, Vol 86, Num 2, pp 278-280, issn 0007-0912Conference Paper

A study of dapsone syndrome at a rural teaching hospital in South IndiaPRASAD, P. V. S.Indian Journal of Dermatology Venereology and Leprology. 2000, Vol 66, Num 3, pp 136-138, issn 0378-6323Article

Dapsone syndrome : A case studyDESAI, Dipti; MALKANI, Ram; ASWANI, Vijay et al.Indian Journal of Dermatology Venereology and Leprology. 2000, Vol 66, Num 5, pp 236-237, issn 0378-6323Article

A Short History of Dapsone, or an Alternative Model of Drug DevelopmentBARR, Justin.Pharmacy in history. 2011, Vol 53, Num 4, pp 123-147, issn 0031-7047, 25 p.Article

Dapsone and colchicine inhibit adhesion of neutrophilic granulocytes to epidermal sectionsMODSCHIEDLER, K; WELLER, M; WÖRL, P et al.Archives of dermatological research (Print). 2000, Vol 292, Num 1, pp 32-36, issn 0340-3696Article

Very late relapse of dapsone-induced methaemoglobinemiaMOULIS, Guillaume; BAGHERI, Haleh; SAINT MARTORY, Jacques et al.European journal of clinical pharmacology. 2010, Vol 66, Num 6, pp 645-646, issn 0031-6970, 2 p.Article

Detection of haptenated proteins in organotypic human skin explant cultures exposed to dapsoneROYCHOWDHURY, Sanjoy; CRAM, Albert E; ALY, Al et al.Drug metabolism and disposition. 2007, Vol 35, Num 9, pp 1463-1465, issn 0090-9556, 3 p.Article

Dapsone in the Management of Autoimmune Bullous DiseasesPIETTE, Evan W; WERTH, Victoria P.Immunology and allergy clinics of North America. 2012, Vol 32, Num 2, issn 0889-8561, vii, 317-322 [7 p.]Article

Interaction of Topical Sulfacetamide and Topical Dapsone With Benzoyl PeroxideDUBINA, Meghan I; FLEISCHER, Alan B.Archives of dermatology (1960). 2009, Vol 145, Num 9, pp 1027-1029, issn 0003-987X, 3 p.Article

Effets indésirables de la Disulone® : résultats de l'enquête française de pharmacovigilance = Side effects of Disulone® : results of the French pharmacovigilance inquiryBENEDETTI-BARDET, C; GUY, C; BOUDIGNAT, O et al.Thérapie (Paris). 2001, Vol 56, Num 3, pp 295-299, issn 0040-5957Conference Paper

Dapsone (sulfone) syndromeTHAPPA, D. M; SETHURAMAN, Gomathy.Indian Journal of Dermatology Venereology and Leprology. 2000, Vol 66, Num 3, pp 117-120, issn 0378-6323Article

Acute dapsone intoxication : A pediatric case reportMACDONALD, R. D; MCGUIGAN, M. A.Pediatric emergency care. 1997, Vol 13, Num 2, pp 127-129, issn 0749-5161Article

HLA-B^*13:01 and the Dapsone Hypersensitivity SyndromeZHANG, F.-R; LIU, H; BAO, F.-F et al.The New England journal of medicine. 2013, Vol 369, Num 17, pp 1620-1628, issn 0028-4793, 9 p.Article

Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximabZAJA, Francesco; MARIN, Luciana; CHIOZZOTTO, Marianna et al.American journal of hematology. 2012, Vol 87, Num 3, pp 321-323, issn 0361-8609, 3 p.Article

Health-Related Quality of Life in Patients Poststroke: Dapsone Versus PlaceboCRUZ-CRUZ, Copytzy; ALTAGRACIA-MARTINEZ, Marina; KRAVZOV-JINICH, Jaime et al.The Journal of pharmacy technology. 2012, Vol 28, Num 3, pp 95-99, issn 8755-1225, 5 p.Article

Symptomatic Hyperbilirubinemia Secondary to Dapsone-Induced Hemolysis and Atazanavir TherapyEAST, Jeff; BLANTON, Lucas Scott.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 2, pp 1081-1083, issn 0066-4804, 3 p.Article

A LIQUID CHROMATOGRAPHY MASS SPECTROMETRY METHOD FOR THE DETERMINATION OF SOME PHARMACOLOGICALLY ACTIVE SUBSTANCES VALIDATED USING MILK AS A MATRIXKIBECHU, Rose; SICHILONGO, Kwenga.Journal of liquid chromatography & related technologies. 2012, Vol 35, Num 9-12, pp 1697-1711, issn 1082-6076, 15 p.Article

Myocarditis in dapsone-induced drug reaction with eosinophilia and systemic symptoms—a case report and review of the literatureLI, Wei-Hsuan; LIU, Han-Nan; LEE, Ding-Dar et al.Zhōnghuá pífūkē yīxué zázhì. 2011, Vol 29, Num 2, pp 63-66, issn 1027-8117, 4 p.Article

Pemphigoïde anti-p200: réponse spectaculaire à la dapsone = Anti-p200 pemphigoid: A spectacular response to dapsoneMUNSCH, C; PREY, S; JOLY, P et al.Annales de dermatologie et de vénéréologie. 2011, Vol 138, Num 11, pp 739-742, issn 0151-9638, 4 p.Article

Dapsone efficacy and adverse events in the management of mucous membrane pemphigoidHEGARTY, Anne M; ORMOND, Martyn; SWEENEY, Maureen et al.EJD. European journal of dermatology. 2010, Vol 20, Num 2, pp 223-224, issn 1167-1122, 2 p.Article

Complete atrioventricular block associated with dapsone therapy: a rare complication of dapsone-induced hypersensitivity syndromeZHU, K. J; HE, F. T; JIN, N et al.Journal of clinical pharmacy and therapeutics (Print). 2009, Vol 34, Num 4, pp 489-492, issn 0269-4727, 4 p.Article

Dapsone-responsive histiocytoid Sweet's syndrome associated with Crohn's diseaseSPENCER, Brent; NANAVATI, Amit; GREENE, John et al.Journal of the American Academy of Dermatology. 2008, Vol 59, Num 2, issn 0190-9622, S58-S60, SUPArticle